3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
6
Phase NA
2
Phase EARLY_PHASE1
2
Phase 2
2
Phase 1
1
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
5
Genitourinary
5
Gynecologic
4
Gastrointestinal
4
Head & Neck
3
Other hematologic neoplasm
2
Breast
2
Sarcoma
1
Other neoplasm
1
NET
1
Myeloid
1
Endocrine
1
Dermatologic
1
CNS
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Hematologic Neoplasms
272
Leukemia, Myeloid, Acute
255
Leukemia
234
Lymphoma
127
Leukemia, Lymphocytic, Chronic, B-Cell
110
Multiple Myeloma
108
Neoplasms
95
Myelodysplastic Syndromes
95
Lymphoma, Non-Hodgkin
94
Hodgkin Disease
76
Burkitt Lymphoma
64
Lymphoma, Mantle-Cell
61
Lymphoma, Follicular
60
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
60
Lymphoma, Large B-Cell, Diffuse
56
Myeloproliferative Disorders
54
Lymphoma, B-Cell, Marginal Zone
53
Lymphoma, Large-Cell, Immunoblastic
47
Congenital Abnormalities
47
Motor Activity
45
Leukemia, Myeloid, Chronic-Phase
45
Primary Myelofibrosis
43
Lymphoma, T-Cell, Cutaneous
43
Recurrence
41
Sezary Syndrome
39
Mycosis Fungoides
39
Leukemia, Myeloid, Accelerated Phase
38
Neoplasms, Plasma Cell
35
Breast Neoplasms
35
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Neoplasms by Site
×
Other hematologic neoplasm
×
Clear all
NCT06910969
2026-03-03
HORIZONS
Massachusetts General Hospital
Phase NA
Recruiting
350 enrolled
NCT06472089
2025-10-15
BMT-CARE
Massachusetts General Hospital
Phase NA
Recruiting
800 enrolled